Czech Republic – Medicinal product of ATC group L04AC24 with the active ingredient MIRIKIZUMAB

By: Pardubice Region Hospital, a.s.📍 Czech RepublicOpen

Key Information

ReferenceGB-802046-2026
DeadlineDec 18, 2026 12:00 AM
Estimated ValueCZK 5,861,437.00
CategoryAdvertising & Media
Competition TypeICB
Funding SourceSelf-Funded
CountryCzech Republic
AddressKyjevská 44, Pardubice - Pardubice, 53003, Czech Republic
PublishedNov 18, 2026

Description

2. Procedure2.1.ProcedureTitle: Medicinal product of ATC group L04AC24 with the active ingredient MIRIKIZUMABDescription: The subject of the performance of the public order is the provision of continu...

Full details are available after unlocking this tender.